Morgan Adam
SEC CIK 1964335 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Dir, See Notes 2, 3 | 123.7K | $6.06M | — | 7 | 2023-02-22 | 2026-01-30 |
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-01-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Morgan Adam | Dir | A - Grant | $0.00 | +54.0K | 123.7K | +77% | $0 | |
| DI | 2025-08-12 | 2025-08-08 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Morgan Adam | Dir | P - Purchase | $1.50 | +1.77M | 8.75M | +25% | +$2.65M |
| DA | 2025-02-04 | 2025-01-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Morgan Adam | Dir | A - Grant | $0.00 | +17.9K | 69.8K | +35% | $0 |
| D | 2025-02-03 | 2025-01-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Morgan Adam | Dir | A - Grant | $0.00 | +17.9K | 69.8K | +35% | $0 |
| D | 2024-01-19 | 2024-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Morgan Adam | Dir | A - Grant | $0.00 | +13.9K | 51.8K | +37% | $0 |
| DI | 2023-07-25 | 2023-07-21 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Morgan Adam | Dir | P - Purchase | $1.37 | +2.49M | 6.99M | +55% | +$3.41M |
| D | 2023-02-24 | 2023-02-22 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Morgan Adam | Dir, See Notes 2, 3 | A - Grant | $0.00 | +37.9K | 37.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations